YGION BIOMEDICAL
YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
YGION BIOMEDICAL
Social Links:
Industry:
Biotechnology Oncology Therapeutics
Founded:
2022-01-01
Address:
Austria, Pangasinan, Philippines
Country:
Philippines
Website Url:
http://www.ygion.bio
Total Employee:
1+
Status:
Active
Contact:
+43 (0)1 235 01 50
Email Addresses:
[email protected]
Total Funding:
15 M EUR
Current Employees Featured
Founder
Official Site Inspections
http://www.ygion.bio Semrush global rank: 12.3 M Semrush visits lastest month: 118
- Host name: host41.ssl-net.net
- IP address: 213.145.224.70
- Location: Austria
- Latitude: 48.2
- Longitude: 16.3667
- Timezone: Europe/Vienna
More informations about "YGION Biomedical"
YGION Biomedical – Individualized Immunotherapies Against Cancer
YGION Biomedical Awarded Grant from the Austrian Research Promotion Agency to develop Individualized Cancer Immunotherapies Sophie Zettl 2024-06-22T13:15:54+02:00 June 18, …See details»
Company - YGION Biomedical
Company Cancer is a leading global cause of death and emerges from healthy cells transforming into tumor cells due to genetic factors and external influences. Despite the variety of over 100 …See details»
YGION Biomedical - Crunchbase Company Profile & Funding
May 21, 2024 Organization. YGION Biomedical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contact Email [email protected]; Phone Number +43 …See details»
Science - YGION Biomedical
The science behind tomorrow’s cancer treatment At YGION, we are developing a treatment that triggers a tumor-specific immune response in cancer patients. By tapping into the patient's …See details»
YGION Biomedical - LinkedIn
Join YGION Biomedical at BIO-Europe in Stockholm on November 4-6th where we will be discussing partnering and collaboration opportunities around our individualized cancer …See details»
YGION Biomedical GmbH - Vienna BioCenter
YGION Biomedical GmbH YGION Biomedical is an Austrian biotechnology company, dedicated to make individualized cancer immunotherapy a reality. By applying groundbreaking, innovative …See details»
Ygion Biomedical GmbH. (5/21/24). "Press Release: Ygion …
YGION Biomedical is a private preclinical stage biopharmaceutical company located in Vienna, Austria committed to realizing individualized immunotherapies against cancer. YGION’s …See details»
Ygion Biomedical GmbH - life-sciences-europe.com
May 26, 2022 YGION Biomedical is a private preclinical stage biopharmaceutical company located in Vienna, Austria committed to realizing individualized immunotherapies against …See details»
YGION Biomedical Secures €15 Million in Series A Funding for …
Founded in 2022, YGION comprises a team of experienced biotech professionals and entrepreneurs committed to developing individualized cancer vaccines. Through proprietary …See details»
YGION Biomedical - PitchBook
YGION Biomedical was founded in 2022. Where is YGION Biomedical headquartered? YGION Biomedical is headquartered in Vienna, Austria. What is the size of YGION Biomedical? …See details»
YGION Biomedical announces €15 Million Series A Financing to …
May 21, 2024 About YGION Biomedical YGION Biomedical is a private preclinical stage biopharmaceutical company located in Vienna, Austria committed to realizing individualized …See details»
YGION Biomedical announces €15 Million Series A Financing
VIENNA, May 21, 2024 /PRNewswire/ -- YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the …See details»
YG-01 cancer vaccine (Ygion Biomedical) - life-sciences-europe.com
May 21, 2024 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
YGION Biomedical announces €15 Million Series A Financing to …
May 21, 2024 YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A financing …See details»
YGION Biomedical announces €15 Million Series A Financing
YGION Biomedical announces €15 Million Series A Financing ... - BioSpaceSee details»
YGION Biomedical announces €15 Million Series A Financing to …
May 21, 2024 YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A financing …See details»
News - Vienna BioCenter
YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, has announced the completion of a Series A financing round of €15 million …See details»
Ygion Biomedical raises series A financing to develop ... - BioWorld
May 21, 2024 Ygion Biomedical GmbH has completed a series A financing round of €15 million (US$ 16.3 million) to support the development of individualized neoantigen-based cancer …See details»
News - YGION Biomedical
Sep 24, 2024 The YGION Biomedical team will be attending a number of international conferences this Autumn. To explore partnerships in Asia and beyond, the team will be joining …See details»
YGOrganization | Yu-Gi-Oh! news that ends misinformation
YGOrganization is the world’s most reliable information source for all Yu-Gi-Oh! news and content.See details»